| | | 68143 | | 13.07.2021 | | Incyte Biosciences International Sàrl | | | | | | | 13.07.2024 | | | | | | 07.16.10. | | | | 07.16.10. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Pemazyre 4,5 mg | comprimés | Tabletten (Pemigatinibum 4.5 mg) | L01EN02 | PI | | 02 | Pemazyre 9 mg | comprimés | Tabletten (Pemigatinibum 9 mg) | L01EN02 | | | 03 | Pemazyre 13,5 mg | comprimés | Tabletten (Pemigatinibum 13.5 mg) | L01EN02 | |
|
|
